skinny.

Latest / Lung Cancer Considered

FDA Approval: Maintenance Lurbinectedin for SCLC

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on the phase III IMforte trial. Dr. Hossein Borghaei joins the podcast to explain the results and offer perspective on the impact of maintenance therapy for SCLC. Guest: Dr. Hossein Borghaei, DO, MS Chief, Division of Thoracic Medical Oncology Professor, Department of Hematology/Oncology Fox Chase Cancer Center

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.